Social Media Content Creators Fueling Parallel Market for Unlicensed Weight-Loss Medication

A shadow economy for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Express Worries

However, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Content Removal

According to the social media company, the service has removed violative content and banned associated hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at residence.

After minutes of joining one group, a vendor shared contact information, where most transactions occur. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Pricing

Inside these communities, messages display dark colored parcels with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.